Clindamycin Phosphate NDC 50090-6072

NDC codes

FDA NDC Directory

Product NDC (as listed)50090-6072Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50090-6072Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
50090-6072-0	50090607200	1 TUBE in 1 CARTON (50090-6072-0) / 30 g in 1 TUBEMarketed from Sep 13, 2022

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Clindamycin Phosphate
Generic name (nonproprietary): clindamycin phosphate
Active ingredients: Clindamycin phosphate — 10 mg/g
Dosage form: Gel
Route: Topical
Labeler: A-S Medication Solutions
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 214251
Marketing start: Mar 10, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Sebaceous Gland Activity (Physiologic effect)Lincosamides (Chemical structure)Neuromuscular Blockade (Physiologic effect)
Identifiers: Product ID 50090-6072_a7ecdce0-55e3-4bc0-8df6-f0116f216659SPL ID a7ecdce0-55e3-4bc0-8df6-f0116f216659SPL set ID c205b9e8-3f62-4176-be4e-bc4b5dbf3893RxCUI 2676585UNII EH6D7113I8
Pharmacologic class: Lincosamide Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450090607200 followed by a unit qualifier and the quantity

Package 50090-6072-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 25, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Clindamycin phosphate gel is indicated in the treatment of acne vulgaris. In view of the potential for diarrhea, bloody diarrhea and pseudomembranous colitis, the physician should consider whether other agents are more appropriate (see CONTRAINDICATIONS , WARNINGS and ADVERSE REACTIONS ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 214251

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 214251
Product	Strength	Form · route	Labeler	Product NDC
Clindamycin Phosphate	Clindamycin phosphate 10 mg/g	GelTopical	NORTHSTAR RX LLC	16714-161
Clindamycin Phosphate	Clindamycin phosphate 10 mg/g	GelTopical	GLENMARK PHARMACEUTICALS INC., USA	68462-866